Company news

Liaoning Chengda Biotechnology Co. Ltd. news in 2025

Liaoning Chengda Biotechnology Co. Ltd.'s news releases, calls and decks from 2025, newest first.

View company

Announcement on Adjusting the Internal Investment Structure of Partial Investment Projects Financed by Raised Funds

December 18, 2025

Announcement on the Postponement of Certain Fundraising Projects, Adjustment of Internal Investment Structure, and Capital Injection to Wholly-owned Subsidiaries for the Implementation of New Fundraising Subprojects

December 5, 2025

Announcement on Convening the Q3 2025 Performance Briefing

November 20, 2025

Announcement on Using Partial Idle Raised Funds for Cash Management

October 29, 2025

Announcement on Voluntary Disclosure of Signing Strategic Cooperation Agreement

October 21, 2025

Announcement on Convening the 2025 Semi-annual Performance Briefing

September 1, 2025

Special Report on Semi-annual Deposit and Actual Use of Raised Funds in 2025

August 28, 2025

Announcement on the 1st Repurchase of Repurchased Shares through Call Auction

August 25, 2025

Announcement on Change of Directors of the Company

August 12, 2025

Announcement on Changing the Secretary of the Board of Directors

July 29, 2025

Announcement on Shareholding of Top 10 Shareholders and Top 10 Shareholders Without Sales Limit Concerning Shares Repurchase

June 24, 2025

Announcement on Resolution of the 19th Meeting of the 5th Board of Directors

June 19, 2025

Indicative Announcement on the Chairman's Proposal to Repurchase the Company's Shares

June 17, 2025

Announcement on Implementation of Dividend Distribution of 2024

June 3, 2025

Announcement on Resolution of the 2024 Annual General Meeting

May 14, 2025

Report for Q1 2025

April 29, 2025

Announcement on Convening Performance Briefing for 2024 and Q1 2025

April 24, 2025

Notice on Convening the 2024 Annual General Meeting

April 23, 2025

Announcement on Listing and Circulation of Some Restricted Stocks in Initial Public Offering

April 18, 2025

Announcement on Completion of Share Delivery for Tender Offer for Company Shares by Shaoguan Gaoteng Enterprise Management Co., Ltd.

April 11, 2025

Announcement on Result of Tender Offer and Stock Resumption for Shaoguan Gaoteng Enterprise Management Co., Ltd.

April 7, 2025

Announcement on Expiration of Tender Offer and Stock Suspension of Shaoguan Gaoteng Enterprise Management Co., Ltd.

April 3, 2025

Third Indicative Announcement on Tender Offer for Company Shares by Shaoguan Gaoteng Enterprise Management Co., Ltd.

March 27, 2025

Second Indicative Announcement on Tender Offer for Company Shares by Shaoguan Gaoteng Enterprise Management Co., Ltd.

March 20, 2025

Announcement on Voluntary Disclosure of the Entry of the Human Papillomavirus15-valent Vaccine (Escherichia Coli) into Phase II Clinical Trials

March 19, 2025

First Indicative Announcement on Tender Offer for Company Shares by Shaoguan Gaoteng Enterprise Management Co., Ltd.

March 13, 2025

Indicative Announcement on Completion of Change of Actual Controller

March 2, 2025

Announcement on Preliminary Earnings Estimate for 2024

February 25, 2025